I'd like to send this letter by v-tada super 20 erfahrungen In the study run by Transparency Life Sciences (TLS), a US-based biopharmaceutical concern that uses open-innovation techniques to design and deliver clinical trials involving ‘repurposed’ off-patent compounds, most of the biometric and patient-reported outcomes will be collected through AMC Health’s telemonitoring platform.